DAM
XERS icon

Deltec Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Deltec Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,000
Closed -$47.5K – 180
2024
Q4 		$47.5K Hold
14,000
– – 0.01% 157
2024
Q3 		$39.9K Hold
14,000
– – 0.01% 151
2024
Q2 		$31.5K Sell
14,000
-38,000
-73% -$76.6K 0.01% 152
2024
Q1 		$115K Sell
52,000
-207,246
-80% -$536K 0.02% 146
2023
Q4 		$609K Sell
259,246
-56,000
-18% -$103K 0.14% 107
2023
Q3 		$586K Sell
315,246
-90,944
-22% -$208K 0.13% 106
2023
Q2 		$1.06M Sell
406,190
-215,882
-35% -$550K 0.23% 85
2023
Q1 		$1.01M Buy
622,072
+253,146
+69% +$317K 0.25% 89
2022
Q4 		$491K Sell
368,926
-169,000
-31% -$239K 0.14% 116
2022
Q3 		$839K Buy
537,926
+131,926
+32% +$218K 0.21% 95
2022
Q2 		$625K Buy
406,000
+158,000
+64% +$333K 0.15% 119
2022
Q1 		$635K Sell
248,000
-163,000
-40% -$398K 0.11% 133
2021
Q4 		$1.2M Sell
411,000
-49,500
-11% -$107K 0.2% 74
2021
Q3 		$1.13M Buy
460,500
+185,000
+67% +$537K 0.17% 90
2021
Q2 		$1.12M Sell
275,500
-315,588
-53% -$1.2M 0.15% 96
2021
Q1 		$2.67M Sell
591,088
-102,782
-15% -$554K 0.4% 55
2020
Q4 		$3.41M Sell
693,870
-159,262
-19% -$797K 0.52% 47
2020
Q3 		$5.06M Buy
853,132
+596,000
+232% +$2.38M 0.9% 28
2020
Q2 		$684K Buy
+257,132
New +$895K 0.14% 126

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Deltec Asset Management's XERS Position: Q1 2025 in Review

Deltec Asset Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2025, closing a stake of 14,000 shares — an estimated $47.5K sold.

Deltec Asset Management first reported a position in XERS in Q2 2020 and held it in 19 quarters. The position peaked at $5.06M in Q3 2020. 199 funds tracked by Wall St. Rank hold XERS as of Q1 2025.

  • Deltec Asset Management reported no remaining Xeris Biopharma Holdings position as of Q1 2025 after selling out during the quarter.
  • Deltec Asset Management sold 14,000 Xeris Biopharma Holdings shares in Q1 2025, an estimated $47.5K.
  • Deltec Asset Management first reported a position in Xeris Biopharma Holdings in Q2 2020 and held it in 19 quarters.
  • Deltec Asset Management's Xeris Biopharma Holdings position peaked at $5.06M in Q3 2020.
  • 199 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2025.

Based on Deltec Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.